Nevertheless, what we need to be aware of is TRIB1’s role in macrophage differentiation, particularly M2-like macrophages, as detailed in previous study [13], which suggests TRIB1 may influence MDS’s immune microenvironment, offering a new research angle beyond its direct genetic impact, potentially affecting therapeutic strategies. Here, TRIB1 is linked to myelodysplastic syndrome.